Welcome to YLOAN.COM
yloan.com » Top7-or-Top10-Tips » Aarkstore Enterprise -growth Performance, Strategies And Swot Analysis:the Top 10 Pharmaceutical Co
Marketing Advertising Branding Careers-Employment Change-Management Customer Service Entrepreneurialism Ethics Marketing-Direct Negotiation Outsourcing PR Presentation Resumes-Cover-Letters Sales Sales-Management Sales-Teleselling Sales-Training Strategic-Planning Team-Building Top7-or-Top10-Tips Workplace-Communication aarkstore corporate advantages development collection global purchasing rapidshare grinding wildfire shipping trading economy wholesale agency florida attorney strategy county consumer bills niche elliptical

Aarkstore Enterprise -growth Performance, Strategies And Swot Analysis:the Top 10 Pharmaceutical Co

The Top 10 Pharmaceutical Companies in Latin America: Growth performance

, strategies and SWOT analysis

Table of Contents :

The Top 10 Pharmaceutical Companies in Latin America

Executive summary 14


Industry overview 14

Sanofi-Aventis 15

Novartis 16

Bayer 17

Pfizer 18

Schering Plough 19

EMS 20

GlaxoSmithKline (GSK) 21

Boehringer Ingelheim 22

Roche 23

J&J (Johnson & Johnson) 24

Chapter 1 Introduction 26

What is this report about? 26

Methodology 26

Chapter 2 Industry overview 30

Summary 30

Introduction 31

Latin American market: size and growth 31

Key market drivers and resistors 33

Market drivers 33

Market resistors 34

Competitive landscape 35

Competitive position of the top 10 companies 35

Comparative analysis of the top 10 companies 37

Trends in the Latin American market 39

Regulatory environment in Latin America 39

Intellectual property 39

Brazil 39

Mexico 40

Venezuela 40

Argentina 41

Rising trial registrations 41

Regulatory harmonization and collaborations 41

Compulsory licensing trends in Latin America 41

Generic drug policy 42

Prescription policies 43

Chapter 3 Sanofi-Aventis 46

Summary 46

Introduction 47

Geographic focus 47

Marketed products 49

Therapeutic focus 49

Research and development 50

Growth strategies 51

Strengthening presence in Latin America 52

Growing business in the vaccine sector 52

SWOT analysis 53

Chapter 4 Novartis 56

Summary 56

Introduction 57

Geographic focus 57

Marketed products 59

Therapeutic focus 59

Research and development 60

Growth strategies 61

Sandoz, second largest generic player globally 61

Glivec/Gleevec positioned as flagship Novartis brand 62

Breadth of prescription pharma portfolio to provide insulation against generic threats 62

Diversification, the corporate mantra at Novartis 63

SWOT analysis 63

Chapter 5 Bayer 66

Summary 66

Introduction 67

Geographic focus 67

Marketed products 69

Therapeutic focus 69

Research and development 71

Growth strategies 71

Focus in healthcare for long-term profitability 71

New products, key for success in Latin America 72

SWOT analysis 73

Chapter 6 Pfizer 76

Summary 76

Introduction 77

Geographic focus 77

Marketed products 78

Therapeutic focus 79

Research and development 80

Growth strategies 81

M&A activities to drive sales 81

Broader therapy focus 82

SWOT analysis 83

Chapter 7 Schering Plough 86

Summary 86

Introduction 87

Geographic focus 87

Marketed products 88

Therapeutic focus 89

Research and development 90

Growth strategies 91

M&A activities to increase the companies revenue generation 91

Building a more diverse prescription drug offering to protect revenues 92

SWOT analysis 93

Chapter 8 EMS 96

Summary 96

Introduction 97

Geographic focus 97

Marketed products 98

Therapeutic focus 98

Research and development 99

Growth strategies 99

SWOT analysis 100

Chapter 9 GSK (GlaxoSmithKline) 102

Summary 102

Introduction 103

Geographic focus 103

Marketed products 104

Therapeutic focus 105

Research and development 106

Growth strategies 107

Growing diversified global business 108

Development of vaccine business 108

Continued investment in biologics 109

Delivering more products of value to the market 109

Simplify the operating model to support a diverse and growing business 110

SWOT analysis 111

Chapter 10 Boehringer Ingelheim 114

Summary 114

Introduction 115

Geographic focus 115

Marketed products 116

Therapeutic focus 117

Research and development 118

Growth strategies 119

Broader therapeutic coverage to open a greater range of opportunities 119

SWOT analysis 120

Chapter 11 Roche 122

Summary 122

Introduction 123

Geographic focus 123

Marketed products 124

Therapeutic focus 125

Research and development 126

Growth strategies 127

SWOT analysis 128

Chapter 12 J&J (Johnson & Johnson) 130

Summary 130

Introduction 130

Geographic focus 131

Marketed products 132

Therapeutic focus 132

Research and development 133

Growth strategies 134

Increasing threat of generic exposure Error! Bookmark not defined.

Lifecycle management to retain patients 134

SWOT analysis 135

Chapter 13 Other major players 138

AstraZeneca 138

Introduction 138

Geographic focus 138

Marketed products 140

Therapeutic focus 140

Research and development 142

Ache Labs 142

Introduction 142

Geographic focus 143

Marketed products 143

Therapeutic focus 144

Research and development 145

Medley 146

Introduction 146

Geographic focus 147

Marketed products 148

Therapeutic focus 148

Research and development 149

Merck & Co. 150

Introduction 150

Geographic focus 150

Marketed products 152

Therapeutic focus 152

Research and development 154

Merck KGaA 154

Introduction 154

Geographic focus 155

Marketed products 156

Therapeutic focus 156

Research and development 157

Nycomed Pharma 158

Introduction 158

Geographic focus 159

Marketed products 160

Therapeutic focus 161

Research and development 162

Eli Lilly 162

Introduction 162

Geographic focus 163

Marketed products 164

Therapeutic focus 164

Research and development 165

Wyeth 166

Introduction 166

Geographic focus 167

Marketed products 167

Therapeutic focus 168

Research and development 169

Eurofarma 170

Introduction 170

Geographic focus 170

Marketed products 172

Therapeutic focus 172

Research and development 173

Teva 174

Introduction 174

Geographic focus 175

Marketed products 176

Therapeutic focus 176

Research and development 177

Glossary 178

Index 179

List of Figures

Figure 2.1: Latin American pharmaceutical market comparison by Y-o-Y growth and CAGR (2004-08) 32

Figure 2.2: Market position of the top 10 pharmaceutical companies in Latin America, 2008 33

Figure 2.3: Key market drivers and resistors of Latin American 35

Figure 2.4: Share of top 10 pharmaceutical companies in Latin American market, 2008 36

Figure 2.5: Comparative analysis of top 10 companies 38

Figure 3.6: Sanofi-Aventis revenue breakdown by geography in Latin America, 2007-08 48

Figure 3.7: Sanofi-Aventis therapeutic focus in Latin America, 2007-08 50

Figure 3.8: Sanofi-Aventis SWOT analysis 53

Figure 4.9: Novartis revenue breakdown by geography in Latin America, 2007-08 58

Figure 4.10: Novartis therapeutic focus in Latin America, 2007-08 60

Figure 4.11: Novartis SWOT analysis 63

Figure 5.12: Bayers revenue breakdown by geography in Latin America, 2007-08 68

Figure 5.13: Bayers therapeutic focus in Latin America, 2007-08 70

Figure 5.14: Bayers SWOT analysis 73

Figure 6.15: Pfizers revenue breakdown by geography in Latin America, 2007-08 78

Figure 6.16: Pfizers therapeutic focus in Latin America, 2007-08 80

Figure 6.17: Pfizers SWOT analysis 83

Figure 7.18: Schering Ploughs revenue breakdown by geography in Latin America, 2007-08 88

Figure 7.19: Schering Ploughs therapeutic focus in Latin America, 2007-08 90

Figure 7.20: Schering Ploughs SWOT analysis 93

Figure 8.21: EMSs revenue breakdown by geography in Latin America, 2007-08 97

Figure 8.22: EMSs therapeutic focus in Latin America, 2007-08 99

Figure 8.23: EMSs SWOT analysis, 2007-08 100

Figure 9.24: GSKs revenue breakdown by geography in Latin America, 2007-08 104

Figure 9.25: GSKs therapeutic focus in Latin America, 2007-08 106

Figure 9.26: GSKs SWOT analysis 111

Figure 10.27: Boehringer Ingelheims geographic focus in Latin America, 2007-08 116

Figure 10.28: Boehringer Ingelheims therapeutic focus in Latin America, 2007-08 118

Figure 10.29: Boehringer Ingelheims SWOT analysis 120


Figure 11.30: Roches revenue breakdown by geography in Latin America, 2007-08 12

For more information, please contact :

http://www.aarkstore.com/reports/The-Top-10-Pharmaceutical-Companies-in-Latin-America-Growth-performance-strategies-and-SWOT-analysis-45477.html

by: aarkstore enterprise
Hot Tips for Choosing Mattresses Single Beds Battling Morning Fatigue : Tips To Overcome The Feeling Tips for Adding Color to Fashion Illustrations 3 Tips For Properly Using An Hdmi Splitter 3 Tips For Rca Connector Wiring First Date Tips for Men Bob Beaulaurier gives tips to CEOs and others on how to perform employee research in CEO Refresher Article Keyword Density - The Essential Tips 3 Tips To Buying An LCD HDTV Television - Guide To Buying an HDTV TV SEO Company Tips: Optimizing Wordpress Blog For Better Search Rankings Top 10 Event Planning Tips Find Better Skincare Tips Tips on the Dealing With College Application Process
print
www.yloan.com guest:  register | login | search IP(216.73.216.173) California / Anaheim Processed in 0.021150 second(s), 7 queries , Gzip enabled , discuz 5.5 through PHP 8.3.9 , debug code: 492 , 9782, 149,
Aarkstore Enterprise -growth Performance, Strategies And Swot Analysis:the Top 10 Pharmaceutical Co Anaheim